Answer
No, somatropin must not be used with any evidence of tumour activity; intracranial tumours must be inactive and antitumour therapy completed before starting treatment, which should be discontinued if tumour growth occurs.
Sources for this answer
- Norditropin FlexPro 5mg/1.5mL, 10mg/1.5mL, 15mg/1.5mLNovo Nordisk Limited · emc · SmPC §4.3 Contraindications · Version 28Document updated
Sources checked